GoodRx Holdings (GDRX) Long-Term Debt Repayments (2019 - 2026)
GoodRx Holdings' Long-Term Debt Repayments history spans 7 years, with the latest figure at $1.2 million for Q4 2025.
- On a quarterly basis, Long-Term Debt Repayments changed N/A to $1.2 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.0 million, a 99.22% decrease, with the full-year FY2025 number at $5.0 million, down 99.22% from a year prior.
- Long-Term Debt Repayments hit $1.2 million in Q4 2025 for GoodRx Holdings, roughly flat from $1.2 million in the prior quarter.
- Over the last five years, Long-Term Debt Repayments for GDRX hit a ceiling of $633.8 million in Q3 2024 and a floor of -$1000.0 in Q4 2023.
- Historically, Long-Term Debt Repayments has averaged $34.9 million across 5 years, with a median of $1.8 million in 2021.
- Biggest five-year swings in Long-Term Debt Repayments: tumbled 100.06% in 2023 and later surged 35970.86% in 2024.
- Tracing GDRX's Long-Term Debt Repayments over 5 years: stood at $1.8 million in 2021, then changed by 0.0% to $1.8 million in 2022, then tumbled by 100.06% to -$1000.0 in 2023, then soared by 63376600.0% to $633.8 million in 2024, then plummeted by 99.8% to $1.2 million in 2025.
- Business Quant data shows Long-Term Debt Repayments for GDRX at $1.2 million in Q4 2025, $1.2 million in Q3 2025, and $1.2 million in Q2 2025.